PLRX: Pliant Therapeutics, Inc. Stock

by  •  • Comments Off on PLRX: Pliant Therapeutics, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 85.90
Enterprise Value ($M) 24.25
Book Value ($M) 257.16
Book Value / Share 4.19
Price / Book 0.33
NCAV ($M) 223.59
NCAV / Share 3.64
Price / NCAV 0.38

Profitability (mra)
Return on Invested Capital (ROIC) -0.69
Return on Assets (ROA) -0.42
Return on Equity (ROE) -0.50

Liquidity (mrq)
Quick Ratio 11.03
Current Ratio 11.03

Balance Sheet (mrq) ($M)
Current Assets 311.19
Assets 344.77
Liabilities 87.61
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -228.37
Net Income -210.30

Cash Flow Statement (mra) ($M)
Cash From Operations -155.50
Cash from Investing 140.34
Cash from Financing 23.12

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
03-10 13D Tang Capital Management Llc 9.60
03-07 13G/A Fmr Llc 0.20 -96.67
02-14 13G/A Redmile Group, LLC 4.80 -9.45
11-14 13G/A Price T Rowe Associates Inc /md/ 8.00 27.63
11-14 13G/A First Light Asset Management, LLC 3.21 -46.94
11-14 13G/A Blue Owl Capital Holdings LP 4.94 0.00
11-12 13G/A Laurion Capital Management LP 0.00 -100.00
10-04 13G Paradigm Biocapital Advisors LP 5.03

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-05-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2025-03-03 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2024-11-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2024-08-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-05-09 125,778 479,127 26.25
2025-05-08 291,040 743,916 39.12
2025-05-07 167,336 574,584 29.12
2025-05-06 234,499 576,884 40.65
2025-05-05 139,853 373,933 37.40

(click for more detail)

Similar Companies
PGEN – Precigen, Inc. PHAT – Phathom Pharmaceuticals, Inc.
PHVS – Pharvaris N.V. PMVP – PMV Pharmaceuticals, Inc.
PRAX – Praxis Precision Medicines, Inc.


Financial data and stock pages provided by
Fintel.io